At our Science Day event, we shared how we're building Moderna for the next decade and beyond.
In his latest blog post, our CEO Stéphane Bancel outlines our three-horizon strategy—executing on today's commercial opportunities while advancing new modalities and investing in science, AI and platform innovation that will help shape the next generation of mRNA medicines.
Read more: